Biotechnology Stocks I Performance Guide: CRISPR Therapeutics AG (CRSP)
CRSP has no dividends.
Table and Chart of CRSP Performance
See what a $1,000 investment in CRSP is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CRSP Returns | |
|---|---|
| Start Date | Nov-30-2016 |
| Start Price | $21.82 |
| End Date | Oct-11-2024 |
| End Price | $46.85 |
| # Prices | 96 |
| Min Date | May-31-2017 |
| Min Price | $13.62 |
| Max Date | Jan-29-2021 |
| Max Price | $165.70 |
| Total Return | 114.71% |
| Annualized Return | 10.02% |
| Current Value of $1,000 Purchase | $2,147 |
| Number Returns | 4,560 |
| Average Return | 81.86% |
| Number Profitable Returns | 3,041 |
| Percent Profitable Returns | 66.69% |
| Number Unprofitable Returns | 1,519 |
| Percent Unprofitable Returns | 33.31% |
| Profitable to Unprofitable Returns Ratio | 2.00 |
| CRSP Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 14.160 | Price to Sales | 23.36 |
| Earnings per Share | $0.0000 |
| PE Ratio | -335172992 |
| PE to Growth Ratio | None |
| Price to Book | 19.73 |
| PRICE DATA | |
| 52 Week High | $1.672 |
| 52 Week Low | $91.1 |
| Analyst Target Price | $-0.993 |
| 50-Day Moving Average | $37.55 |
| 200-Day Moving Average | $47.24 |
| FINANCIAL DATA | |
| Revenue per Share | $-3.2 |
| Revenue | $0 |
| Profit Margin | 248.3% |
| Return on Equity | -9.77% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CRSP Compare Returns with S&P 500
CRSP Trendline Chart
CRSP Moving Average Chart
CRSP Stock Return Map - See Patterns of Gains and Losses
CRSP Stock Returns/Purchase Dates